Fig. 3
From: Ferroptosis in cardiovascular diseases: role and mechanism
Ferroptosis-related cardiovascular diseases and potential treatment reagents. Ferroptosis is involved in the occurrence and progression of ischemia perfusion injury, atrial fibrillation, chemotherapy-related cardiomyopathy, diabetes-related cardiomyopathy, myocardial hypertrophy, and COVID-19-related cardiomyopathy. Molecules and drugs targeting ferroptosis may ameliorate these ferroptosis-related heart diseases, and they include SMI, SSYXC, melatonin, curcumin, ferrostatin-1, and deferoxamine